Nuvation Bio NUVB Deferred Tax Assets, Operating Loss Carryforwards
Deferred Tax Assets, Operating Loss Carryforwards at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwards.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's deferred tax assets, operating loss carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's deferred tax assets, operating loss carryforwards?
- Nuvation Bio (NUVB) reported deferred tax assets, operating loss carryforwards of $127.35M in Q4 2025.
- How has Nuvation Bio's deferred tax assets, operating loss carryforwards changed year-over-year?
- Nuvation Bio's deferred tax assets, operating loss carryforwards increased by 18.2% year-over-year, from $107.7M to $127.35M.
- What is the long-term trend for Nuvation Bio's deferred tax assets, operating loss carryforwards?
- Over 5 years (2020 to 2025), Nuvation Bio's deferred tax assets, operating loss carryforwards has grown at a 95.8% compound annual growth rate (CAGR), from $4.43M to $127.35M.